Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention.
Ambrose
J A
JA
Department of Medicine, Division of Cardiology, Saint Vincent's Hospital & Medical Center, New York, NY 10011, USA. jambrose@saintvincentsnyc.org
Doss
R
R
Geagea
J M
JM
Hawkey
M C
MC
Duvuri
S
S
Giedd
K
K
Dominguez
A
A
Coppola
J
J
Nguyen
T H
TH
Palla
V
V
Barua
R S
RS
Saha
D C
DC
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000925:Anticoagulants / Q000008:administration & dosage; D017225:Atherectomy, Coronary; D003327:Coronary Disease / Q000097:blood / Q000628:therapy*; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000097:blood; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011516:Prothrombin; D015607:Stents; D013917:Thrombin / Q000378:metabolism*; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014914:Whole Blood Coagulation Time
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010446:Peptide Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; C045879:prothrombin fragment 1.2; D014443:Tyrosine; D011516:Prothrombin; D006493:Heparin; D013917:Thrombin; D000077466:Tirofiban; D000077284:Abciximab